Phase III open label, randomized, Study of the cancer stem cell inhibitor BBI-608 plus nab-paclitaxel with gemcitabine (Arm 1) versus nab-paclitaxel with gemcitabine (Arm 2) in metastatic pancreatic adenocarcinoma - Regional Cancer Care Associates LLC

Clinical Trials

Phase III open label, randomized, Study of the cancer stem cell inhibitor BBI-608 plus nab-paclitaxel with gemcitabine (Arm 1) versus nab-paclitaxel with gemcitabine (Arm 2) in metastatic pancreatic adenocarcinoma

Type of Cancer
Pancreatic
Locations
East Brunswick
Freehold
Howell
Little Silver
Marmora
Mount Holly
Sparta
Sponsor
Boston Biomedical Inc
Protocol Number
CanStem111P
Cancer Diagnosis
To Learn More Call
201-510-0910